Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maximilian Merz

Showing results (11-20 of 127) with videos related to

Pageof 13
Sort By:
Deutsches Arzteblatt International|April 19, 2023
Antibody-Drug Conjugates as a Targeted Therapeutic Approach Across Entities in OncologyFlorian Lordick, Maximilian Merz, Eva Büch, et al.
Journal for Immunotherapy of Cancer|November 7, 2025
Mileage matters: long-distance performance of CARs in multiple myelomaEric M Jurgens, Saad Z Usmani, Maximilian Merz
Journal of Cancer Research and Clinical Oncology|June 28, 2017
Meeting report of the 6th Heidelberg Myeloma Workshop: current status and developments in diagnosis and therapy of multiple myelomaMaximilian Merz, Marc S Raab, Hartmut Goldschmidt, et al.
Haematologica|February 15, 2024
Functional cure and long-term survival in multiple myeloma: how to challenge the previously impossibleMonika Engelhardt, K Martin Kortüm, Hartmut Goldschmidt, et al.
European Journal of Haematology|August 7, 2023
CAR T cell therapy in multiple myeloma, where are we now and where are we heading for?Luise Fischer, Nora Grieb, Uwe Platzbecker, et al.
Leukemia|April 8, 2025
Emerging T-cell lymphomas after CAR T-cell therapyTill Braun, Florian Kuschel, Kristin Reiche, et al.
BMC Microbiology|March 8, 2024
Characterization of the major autolysin (AtlC) of Staphylococcus carnosusMaximilian Merz, Carolin J Schiffer, Andreas Klingl, et al.
European Journal of Cancer (Oxford, England : 1990)|September 25, 2010
Sorafenib tosylate and paclitaxel induce anti-angiogenic, anti-tumour and anti-resorptive effects in experimental breast cancer bone metastasesMaximilian Merz, Dorde Komljenovic, Stefan Zwick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2010
Drug-induced vessel remodeling in bone metastases as assessed by dynamic contrast enhanced magnetic resonance imaging and vessel size imaging: a longitudinal in vivo studyTobias Bäuerle, Maximilian Merz, Dorde Komljenovic, et al.
European Journal of Radiology|February 3, 2015
Diffusion-weighted imaging and dynamic contrast-enhanced MRI of experimental breast cancer bone metastases--a correlation study with histologyMaximilian Merz, Lisa Seyler, Maren Bretschi, et al.
Pageof 13

Showing results (11-20 of 127) with videos related to

Sort By:
Pageof 13
Deutsches Arzteblatt International|April 19, 2023
Antibody-Drug Conjugates as a Targeted Therapeutic Approach Across Entities in OncologyFlorian Lordick, Maximilian Merz, Eva Büch, et al.
Journal for Immunotherapy of Cancer|November 7, 2025
Mileage matters: long-distance performance of CARs in multiple myelomaEric M Jurgens, Saad Z Usmani, Maximilian Merz
Journal of Cancer Research and Clinical Oncology|June 28, 2017
Meeting report of the 6th Heidelberg Myeloma Workshop: current status and developments in diagnosis and therapy of multiple myelomaMaximilian Merz, Marc S Raab, Hartmut Goldschmidt, et al.
Haematologica|February 15, 2024
Functional cure and long-term survival in multiple myeloma: how to challenge the previously impossibleMonika Engelhardt, K Martin Kortüm, Hartmut Goldschmidt, et al.
European Journal of Haematology|August 7, 2023
CAR T cell therapy in multiple myeloma, where are we now and where are we heading for?Luise Fischer, Nora Grieb, Uwe Platzbecker, et al.
Leukemia|April 8, 2025
Emerging T-cell lymphomas after CAR T-cell therapyTill Braun, Florian Kuschel, Kristin Reiche, et al.
BMC Microbiology|March 8, 2024
Characterization of the major autolysin (AtlC) of Staphylococcus carnosusMaximilian Merz, Carolin J Schiffer, Andreas Klingl, et al.
European Journal of Cancer (Oxford, England : 1990)|September 25, 2010
Sorafenib tosylate and paclitaxel induce anti-angiogenic, anti-tumour and anti-resorptive effects in experimental breast cancer bone metastasesMaximilian Merz, Dorde Komljenovic, Stefan Zwick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2010
Drug-induced vessel remodeling in bone metastases as assessed by dynamic contrast enhanced magnetic resonance imaging and vessel size imaging: a longitudinal in vivo studyTobias Bäuerle, Maximilian Merz, Dorde Komljenovic, et al.
European Journal of Radiology|February 3, 2015
Diffusion-weighted imaging and dynamic contrast-enhanced MRI of experimental breast cancer bone metastases--a correlation study with histologyMaximilian Merz, Lisa Seyler, Maren Bretschi, et al.
Pageof 13